MGNX - MacroGenics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue60,121157,74291,880100,854
Cost of Revenue190,827147,232122,09198,271
Gross Profit-130,70610,510-30,2112,583
Operating Expenses
Research Development-147,232147,232147,232
Selling General and Administrative40,50032,65329,83122,765
Non Recurring----
Others----
Total Operating Expenses231,327179,885151,922121,036
Operating Income or Loss-171,206-22,143-60,042-20,182
Income from Continuing Operations
Total Other Income/Expenses Net-2472,5171,51442
Earnings Before Interest and Taxes-171,206-22,143-60,042-20,182
Interest Expense----
Income Before Tax-171,453-19,626-58,528-20,140
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-171,453-19,626-58,528-20,140
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-171,453-19,626-58,528-20,140
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-171,453-19,626-58,528-20,140